From Targets to Therapies: GPCR-targeted Drug Discovery Trends Revealed by CAS Data

• Conducting a large-scale, data-driven landscape analysis of GPCR-targeted drug discovery using the CAS Content Collection™
• Characterizing temporal trends in GPCR research activity to show shifts in research emphasis that reflect increased interest in underexplored receptors and disease-focused targeting strategies
• Evaluating how therapeutic strategies have diversified, revealing a professional from small-molecule approaches toward a broader range of modalities

Speakers:

Angela Zhou Ph.D.

Manager, Scientific Analysis and Insights

CAS